TotalMarketCap

Abvc Biopharma

ABVCNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$26.297 M

$0.99 -2.46%

Close of 6 Nov 2026

As of 6 Nov 2026, Abvc Biopharma (ABVC) has a market capitalization of $26.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$509.6K

#3511 by revenue

Earnings

-$7.91M

Loss-making

Shares outstanding

26,654,365

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #368Adicet BioACET$27.6M
  2. #369BeyondSpringBYSI$26.6M
  3. #370Abvc BiopharmaABVC$26.3M
  4. #371Transcode TherapeuticsRNAZ$25.4M
  5. #372Aardvark TherapeuticsAARD$24.5M

What if Abvc Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,057,780

Per share 1,073,779× higher

Bitcoin $1.53T

$57,234.62

Per share 58,100× higher

Apple $5.02T

$187,895.90

Per share 190,738× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Abvc Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.